We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[New anti-osteoporotic drugs under development].
Nihon Rinsho. Japanese Journal of Clinical Medicine 2015 October
Cathepsin K is a cysteine protease indispensable for collagen degradation and bone resorption by osteoclasts. Cathepsin K inhibitors suppress bone resorption while keeping osteoclasts alive, which is believed to maintain osteoblast-stimulating activity of osteoclasts. Sclerostin is an osteocyte-derived soluble factor that inhibits the Wnt canonical pathway. Neutralizing antibody against sclerostin strongly but transiently stimulates bone formation. This review will discuss unique actions on bone metabolism and clinical efficacy of these two anti-osteoporotic drugs under development.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app